Shares of Johnson & Johnson (JNJ) ended the trading day Thursday at $157.38,
representing a move of 0.85%, or $1.33 per share, on volume of 5.07 million shares.
Johnson & Johnson is the world’s largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
After opening the trading day at $156.53, shares of Johnson & Johnson traded between a range of $155.11 and $157.66. Johnson & Johnson currently has a total float of 2.63 billion
shares and on average sees n/a shares exchange hands each day.
The stock now has a 50-day SMA of $n/a and 200-day SMA of $n/a, and it has a high of $157.00 and low of $109.17 over the last year.
Johnson & Johnson is based out of New Brunswick, NJ, and has 132,200 employees. The company’s CEO is Alex Gorsky.
Still paying commissions on stock trades? Equities.com now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by https://www.equities.com/trading-start
GET TO KNOW THE DOW
The Dow Jones Industrial Average is the oldest and most-often cited stock market index for the American equities market. Along
with other major indices such as the S&P 500 and Nasdaq, it remains one of the most visible representations of the stock market to the outside world. The index consists of 30 blue chip companies and
is a price-weighted index as opposed to a market-cap weighted index. This approach has made it somewhat controversial among market watchers. (See: Opinion: The DJIA is a Relic and We Need to Move On)
The history of the index dates all the way back to 1896 when it was first created by Charles Dow, the legendary founding editor of the Wall Street Journal and founder of Dow Jones & Company, and
Edward Jones, a statistician. The price-weighted, scaled index has since become a standard part of most major daily news recaps and has seen dozens of different companies pass through its ranks,
with only General Electric ($GE) remaining on the index since its inception.
To get more information on Johnson & Johnson and to follow the company’s latest updates, you can visit the company’s profile page here:
JNJ’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s
Newsdesk. Also, don’t forget to sign-up for our daily
email newsletter to ensure you don’t miss out on any of our best stories.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.
The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer